BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12165556)

  • 1. Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease.
    Chan EY; Luthi-Carter R; Strand A; Solano SM; Hanson SA; DeJohn MM; Kooperberg C; Chase KO; DiFiglia M; Young AB; Leavitt BR; Cha JH; Aronin N; Hayden MR; Olson JM
    Hum Mol Genet; 2002 Aug; 11(17):1939-51. PubMed ID: 12165556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.
    Bradford J; Shin JY; Roberts M; Wang CE; Sheng G; Li S; Li XJ
    J Biol Chem; 2010 Apr; 285(14):10653-61. PubMed ID: 20145253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum.
    Mende-Mueller LM; Toneff T; Hwang SR; Chesselet MF; Hook VY
    J Neurosci; 2001 Mar; 21(6):1830-7. PubMed ID: 11245667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis.
    Kim YJ; Yi Y; Sapp E; Wang Y; Cuiffo B; Kegel KB; Qin ZH; Aronin N; DiFiglia M
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12784-9. PubMed ID: 11675509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice.
    Orr AL; Huang S; Roberts MA; Reed JC; Li S; Li XJ
    J Biol Chem; 2008 Jun; 283(23):16027-36. PubMed ID: 18400759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.
    Boudreau RL; McBride JL; Martins I; Shen S; Xing Y; Carter BJ; Davidson BL
    Mol Ther; 2009 Jun; 17(6):1053-63. PubMed ID: 19240687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype onset in Huntington's disease knock-in mice is correlated with the incomplete splicing of the mutant huntingtin gene.
    Franich NR; Hickey MA; Zhu C; Osborne GF; Ali N; Chu T; Bove NH; Lemesre V; Lerner RP; Zeitlin SO; Howland D; Neueder A; Landles C; Bates GP; Chesselet MF
    J Neurosci Res; 2019 Dec; 97(12):1590-1605. PubMed ID: 31282030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice.
    Rodriguez-Lebron E; Denovan-Wright EM; Nash K; Lewin AS; Mandel RJ
    Mol Ther; 2005 Oct; 12(4):618-33. PubMed ID: 16019264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear translocation of STAT5 initiates iron overload in huntington's disease by up-regulating IRP1 expression.
    Niu L; Zhou Y; Wang J; Zeng W
    Metab Brain Dis; 2024 Apr; 39(4):559-567. PubMed ID: 38261161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4h knockdown.
    Cheng HM; Chern Y; Chen IH; Liu CR; Li SH; Chun SJ; Rigo F; Bennett CF; Deng N; Feng Y; Lin CS; Yan YT; Cohen SN; Cheng TH
    PLoS Genet; 2015 Mar; 11(3):e1005043. PubMed ID: 25760041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington's disease pathogenesis.
    Xu S; Li G; Ye X; Chen D; Chen Z; Xu Z; Daniele M; Tambone S; Ceccacci A; Tomei L; Ye L; Yu Y; Solbach A; Farmer SM; Stimming EF; McAllister G; Marchionini DM; Zhang S
    PLoS Genet; 2022 Jul; 18(7):e1010302. PubMed ID: 35853002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ovine transgenic Huntington's disease model.
    Jacobsen JC; Bawden CS; Rudiger SR; McLaughlan CJ; Reid SJ; Waldvogel HJ; MacDonald ME; Gusella JF; Walker SK; Kelly JM; Webb GC; Faull RL; Rees MI; Snell RG
    Hum Mol Genet; 2010 May; 19(10):1873-82. PubMed ID: 20154343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cdc42-interacting protein 4 binds to huntingtin: neuropathologic and biological evidence for a role in Huntington's disease.
    Holbert S; Dedeoglu A; Humbert S; Saudou F; Ferrante RJ; NĂ©ri C
    Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2712-7. PubMed ID: 12604778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein.
    Fox JH; Connor T; Stiles M; Kama J; Lu Z; Dorsey K; Lieberman G; Sapp E; Cherny RA; Banks M; Volitakis I; DiFiglia M; Berezovska O; Bush AI; Hersch SM
    J Biol Chem; 2011 May; 286(20):18320-30. PubMed ID: 21454633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity.
    Watkin EE; Arbez N; Waldron-Roby E; O'Meally R; Ratovitski T; Cole RN; Ross CA
    PLoS One; 2014; 9(2):e88284. PubMed ID: 24505464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometric identification of novel lysine acetylation sites in huntingtin.
    Cong X; Held JM; DeGiacomo F; Bonner A; Chen JM; Schilling B; Czerwieniec GA; Gibson BW; Ellerby LM
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.009829. PubMed ID: 21685499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mitochondrial protein import by mutant huntingtin.
    Yano H; Baranov SV; Baranova OV; Kim J; Pan Y; Yablonska S; Carlisle DL; Ferrante RJ; Kim AH; Friedlander RM
    Nat Neurosci; 2014 Jun; 17(6):822-31. PubMed ID: 24836077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Fresh Look at Huntingtin mRNA Processing in Huntington's Disease.
    Romo L; Mohn ES; Aronin N
    J Huntingtons Dis; 2018; 7(2):101-108. PubMed ID: 29865084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlative light and electron microscopy suggests that mutant huntingtin dysregulates the endolysosomal pathway in presymptomatic Huntington's disease.
    Zhou Y; Peskett TR; Landles C; Warner JB; Sathasivam K; Smith EJ; Chen S; Wetzel R; Lashuel HA; Bates GP; Saibil HR
    Acta Neuropathol Commun; 2021 Apr; 9(1):70. PubMed ID: 33853668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Translational Modifications (PTMs), Identified on Endogenous Huntingtin, Cluster within Proteolytic Domains between HEAT Repeats.
    Ratovitski T; O'Meally RN; Jiang M; Chaerkady R; Chighladze E; Stewart JC; Wang X; Arbez N; Roby E; Alexandris A; Duan W; Vijayvargia R; Seong IS; Lavery DJ; Cole RN; Ross CA
    J Proteome Res; 2017 Aug; 16(8):2692-2708. PubMed ID: 28653853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.